Agreement integrates Clyde Biosciences' human-relevant, CellOPTIQ cardiotoxicity screen for chemical safety assessment ...
Future Cardiol. 2012;8(4):647-670. Although redox-induced damage is likely involved in anthracycline-induced cardiotoxicity, some evidence suggests that it is not the only mechanism at play. Several ...
Dexrazoxane reduced the risk for cardiac events and clinical heart failure among women with breast cancer who underwent anthracycline chemotherapy, according to results of a systematic review and meta ...
The prevalence of subclinical cardiotoxicity identified by echocardiographic global longitudinal strain (GLS) in patients with breast cancer taking doxorubicin (Adriamycin) was similar whether ...
Please provide your email address to receive an email when new articles are posted on . Black race was associated with 71% greater odds of chemotherapy-related cardiotoxicity vs. white or non-Black ...
Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human ...
The authors conclude that osimertinib is not significantly associated with developing heart failure on the basis of three large databases: FLAURA, AURA3, and a global safety database sponsored by ...
When compared to cocaine exposure alone, cocaine and ethanol exposure in emergency department (ED) patients with acute drug overdose was significantly associated with higher occurrence of cardiac ...
A previously healthy 78-year-old woman presented with facial flushing, palpitations, diarrhea, and generalized weakness. The serum serotonin level was markedly elevated (2233 ng per milliliter; normal ...
Trastuzumab-mediated cardiotoxicity was originally described in women with metastatic breast cancer. The incidence rates were 13% when the antibody was administered in combination with paclitaxel and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results